EUVIMEDEUVIMED entdecken
Kohortenstudie

74358 Efficacy, Quality-of-Life Improvement, and Predictors of Response to Bimekizumab in Moderate-to-Severe Plaque Psoriasis: A Real-World Prospective Cohort Study

Laura Moreno Hernandez, Andreu Munar Llabrés, Juan Escalas Taberner

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB194

DOI: 10.1016/j.jaad.2026.04.790 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Laura Moreno Hernandez und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hernandez, L. M., Llabrés, A. M., & Taberner, J. E. (2026). 74358 Efficacy, Quality-of-Life Improvement, and Predictors of Response to Bimekizumab in Moderate-to-Severe Plaque Psoriasis: A Real-World Prospective Cohort Study. Journal of the American Academy of Dermatology, 95(1), AB194. https://doi.org/10.1016/j.jaad.2026.04.790

Vancouver

Hernandez LM, Llabrés AM, Taberner JE. 74358 Efficacy, Quality-of-Life Improvement, and Predictors of Response to Bimekizumab in Moderate-to-Severe Plaque Psoriasis: A Real-World Prospective Cohort Study. Journal of the American Academy of Dermatology. 2026;95(1):AB194. doi:10.1016/j.jaad.2026.04.790

BibTeX
@article{Hernandez2026,
  author = {Hernandez, Laura Moreno and Llabrés, Andreu Munar and Taberner, Juan Escalas},
  title = {74358 Efficacy, Quality-of-Life Improvement, and Predictors of Response to Bimekizumab in Moderate-to-Severe Plaque Psoriasis: A Real-World Prospective Cohort Study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB194},
  doi = {10.1016/j.jaad.2026.04.790}
}
Kostenlos starten →